Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
Fractyl Health (Nasdaq: GUTS), a metabolic therapeutics company focusing on obesity and Type 2 Diabetes treatments, has scheduled its third quarter 2024 financial results announcement and business updates for November 12, 2024, at 4:30 p.m. ET. The company will host a live webcast accessible through their investor relations website, with a replay option available after the event.
Fractyl Health (Nasdaq: GUTS), un'azienda di terapie metaboliche focalizzata sul trattamento dell'obesità e del diabete di tipo 2, ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 e aggiornamenti aziendali per il 12 novembre 2024, alle 16:30 ET. L'azienda ospiterà un webcast dal vivo accessibile tramite il loro sito web per relazioni con gli investitori, con un'opzione di replica disponibile dopo l'evento.
Fractyl Health (Nasdaq: GUTS), una empresa de terapias metabólicas enfocada en tratamientos para la obesidad y la diabetes tipo 2, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 y actualizaciones empresariales para el 12 de noviembre de 2024, a las 4:30 p.m. ET. La empresa llevará a cabo una retransmisión en vivo accesible a través de su sitio web de relaciones con inversores, con una opción de repetición disponible después del evento.
Fractyl Health (Nasdaq: GUTS), 비만 및 제2형 당뇨병 치료에 중점을 둔 대사 치료 회사는 2024년 3분기 재무 결과 발표 및 비즈니스 업데이트를 2024년 11월 12일 오후 4시 30분 ET에 예정했습니다. 회사는 투자자 관계 웹사이트를 통해 접근할 수 있는 실시간 웹캐스트를 개최하며, 행사 후 재방송 옵션도 제공됩니다.
Fractyl Health (Nasdaq: GUTS), une entreprise de thérapies métaboliques axée sur les traitements de l'obésité et du diabète de type 2, a prévu l'annonce de ses résultats financiers du troisième trimestre 2024 et des mises à jour commerciales pour le 12 novembre 2024 à 16h30 ET. L'entreprise organisera un webinaire en direct accessible via son site de relations investisseurs, avec une option de rediffusion disponible après l'événement.
Fractyl Health (Nasdaq: GUTS), ein Unternehmen für Stoffwechseltherapien, das sich auf die Behandlung von Fettleibigkeit und Typ-2-Diabetes konzentriert, hat die Bekanntgabe seiner Finanzergebnisse für das dritte Quartal 2024 sowie Unternehmensaktualisierungen für den 12. November 2024 um 16:30 Uhr ET geplant. Das Unternehmen wird ein Live-Webcast veranstalten, der über die Website für Investor Relations zugänglich ist, mit einer Wiederholungsoption, die nach der Veranstaltung verfügbar ist.
- None.
- None.
BURLINGTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D), today announced it will report financial results for the third quarter 2024 and provide business updates on Tuesday, November 12, 2024, at 4:30 p.m. ET.
A live webcast of the conference call can be accessed in the “Events” section of Fractyl’s website at https://ir.fractyl.com/. The webcast will be archived and available for replay following the live event.
About Fractyl Health
Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl Health’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. Fractyl Health is based in Burlington, MA. For more information, visit www.fractyl.com or www.twitter.com/FractylHealth.
Contacts
Corporate Contact
Lisa Davidson, Chief Financial Officer
ir@fractyl.com. 781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
jcotrone@fractyl.com. 978.760.5622
Investor Contact
Stephen Jasper Gilmartin Group
stephen@gilmartinir.com. 619.949.3681
FAQ
When will Fractyl Health (GUTS) report Q3 2024 earnings?
How can I access Fractyl Health's (GUTS) Q3 2024 earnings call?
What is Fractyl Health's (GUTS) main business focus?
